Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
MUMC+ start met zorg op afstand bij diepe hersenstimulatie
aug 2022 | Bewegingsstoornissen